Phase 2 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman aged 18 or older
- You have been diagnosed with a specific type of cervical cancer (squamous cell carcinoma, adenosquamous carcinoma, or adenocarcinoma) confirmed by a tissue test, and have not yet received any treatment for it
- Your cancer has been staged using the FIGO 2018 system as stage IB3, IIA, IIB, IIIA, IIIB, or IIIC
- You are able to give written consent in English, Luganda, Runyankole, or Lango
- You are willing to attend follow-up appointments for up to 12 months after treatment
- Your doctors consider you well enough to receive a chemotherapy drug called cisplatin
- You are generally able to carry out basic daily activities (your doctors will assess this using a standard scale)
- Your blood test results meet certain minimum levels for white blood cells, platelets, red blood cells, and kidney and liver function (confirm with trial site)
- If you are HIV-positive, you have been on a stable HIV treatment (antiretroviral therapy) for at least 6 weeks before joining
Who may not be able to join:
- You have previously had your womb (uterus) removed, either fully or partially (hysterectomy)
- There is evidence that your cancer has spread to distant parts of your body
- You have previously had radiotherapy to your pelvis or abdomen
- You have metal hip replacements on both sides that could interfere with radiotherapy
- You have a history of inflammatory bowel disease or another condition that could cause complications with radiotherapy (confirm with trial site)
- You are pregnant at the time of joining the trial
- You currently have another active cancer that is not being treated
- You have an uncontrolled medical or mental health condition that would make it difficult to follow the trial requirements (confirm with trial site)
- You are HIV-positive with an uncontrolled infection, specifically a viral load above 2,000 copies/mL
- Your CD4 count (a measure of immune system health) is below 200 cells/mm³
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Solomon Kibudde, MBChB, MMed., Uganda Cancer Institute
Phone: +256773004608
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of adverse events (AEs); Incidence of grade 3 or greater radiotherapy-related gastrointestinal or genitourinary AEs; Local control (complete remission, stable disease, and partial response) rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.